Robert D. Thompson
Director Ejecutivo en Lewis & Clark Pharmaceuticals, Inc. .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Edward Williams | M | - |
Lewis & Clark Pharmaceuticals, Inc.
 Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| Joel M. Linden | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| Miette H. Michie | F | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| Larry Rodman | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | 12 años |
| C. Thomas Carter | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| Jeffrey Totten | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| David K. Glover | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| Julien Dimastromatteo | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 8 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Robert D. Thompson
- Red Personal
